Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism-Reference-Cited by-同舟云学术

Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism

Published:2016-11-28 Issue:4 Volume:4 Page:603-606
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Morley James F.¹²,Cheng Gang³⁴,Dubroff Jacob G.³⁴,Wood Stephanie¹,Wilkinson Jayne R.¹²,Duda John E.¹²

Affiliation:

1. Parkinson's Disease Research Education; Clinical and Education Center; Corporal Michael J. Crescenz VA Medical Center; Philadelphia Pennsylvania USA

2. Department of Neurology; University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania USA

3. Division of Nuclear Medicine; Corporal Michael J. Crescenz VA Medical Center; Philadelphia Pennsylvania USA

4. University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania USA

Funder

VA Competitive Pilot Project Fund

GE Healthcare

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mdc3.12458/fullpdf

Reference16 articles.

1. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambui study);Barbosa;Mov Disord,2006

2. Persistent drug-induced parkinsonism;Aronson;Biol Psychiatry,1985

3. Prognosis of drug-induced Parkinson's disease;Wilson;Lancet,1987

4. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?;Lim;Int J Neurosci,2013

5. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases;Rajput;Arch Neurol,1982

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Olfactory Profiles in Parkinson’s Disease and Drug-Induced Parkinsonism;Journal of Movement Disorders;2024-01-31

2. Neuroimaging Techniques in Differentiating Parkinson’s Disease from Drug-Induced Parkinsonism: A Comprehensive Review;Clinics and Practice;2023-11-15

3. Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic;Therapeutics and Clinical Risk Management;2022-12

4. Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism;npj Parkinson's Disease;2022-04-28

5. Olfactory Dysfunction in Parkinson’s Disease and Related Disorders;Non-Motor Parkinson's Disease;2022-03-10